Abel Hall LLC’s Sana Biotechnology SANA Stock Holding History

Abel Hall LLC’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.9K	Buy	+11,972	New	+$41.7K	0.01%	856

Other funds holding SANA

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Foguth Wealth Management Brighton, Michigan $986M AUM 11.51% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return

Abel Hall LLC's SANA Position: Q3 2026 in Review

Abel Hall LLC opened a new position in Sana Biotechnology (SANA) in Q3 2026: 11,972 shares worth $34.9K. The stake represents 0.01% of the portfolio and ranks #856 among its holdings.

21 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

Abel Hall LLC held 11,972 shares of Sana Biotechnology worth $34.9K as of Q3 2026.
Sana Biotechnology was a new Abel Hall LLC position in Q3 2026.
Sana Biotechnology made up 0.01% of Abel Hall LLC's portfolio in Q3 2026, its #856 holding.
21 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.